You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Red Sox Live

5

5

▲  7th Inning 1 outs

Knome appoints Martin Tolar as chief executive

Knome Inc., a Cambridge life sciences company specializing in human genome interpretation, today announced that it has appointed Martin Tolar, M.D., as its chief executive.

Knome supports researchers with the informatics and software tools used to investigate the genetic basis of human disease and drug response.

Continue reading below

Before joining Knome, Tolar was chief executive of Normoxys Inc., where he helped build a management team, secure venture financings, and advance the company’s novel cancer therapeutics from a research project into clinical development, Knome said in a press release.

Jorge Conde, Knome’s founding CEO, will become chief strategy officer and continue to serve on its board of directors, Knome said; in his new role, he will lead the development of Knome’s genome interpretation software and services.

Chris Reidy can be reached at reidy@globe.com.
Loading comments...
Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
or
Please enter a valid email
BostonGlobe.com will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com